Antibody Drug Conjugates (ADCs) are a class of biomolecules that has seen rapid growth with multiple new commercial products. Adoption of single-use (SU) systems has been slow due to concerns about the safe handling of organic solvents and the toxic small molecule payload. Recent advances in single-use technology have overcome these concerns and now provide an understanding of the suitability, scalability, and fluid compatibility of both the single-use components as well as the supporting hardware and controls. In this webinar, we show how single-use technology can deliver consistent and scalable ADC chemistry and functionality with desired final product specifications and high yield.
In this webinar, you will learn:
- How SU assemblies are used in the ADC development space
- Recommendations for consistent transfer of SU processes to manufacturing
- Understand if SU technology is right for your product
- Evaluate the pros and cons of SU for ADCs
Pharma and biopharma manufacturing
- Antibody drug conjugate manufacturing
Doba trvání:1h
Jazyk:English
Relace 1:předložené November 12, 2020
Abyste mohli pokračovat ve čtení, přihlaste se nebo vytvořte účet.
Nemáte účet?